Skip to content

Hysterosalpingography and Hysteroscopy in ICSI

Hysterosalpingography and Hysteroscopy in Intracytoplasmic Sperm Injection

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04778319
Enrollment
200
Registered
2021-03-03
Start date
2021-03-02
Completion date
2022-02-15
Last updated
2021-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

unexplained infertility is a rising problem in clinical practice

Detailed description

Assessment of uterine cavity is very important before ICSI

Interventions

OTHERocclusion of tubes

to occlude the fallopian tubes

OTHERnon occlusion of tubes

not to occlude the tubes

Sponsors

Aljazeera Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 42 Years
Healthy volunteers
No

Inclusion criteria

* women with infertility

Exclusion criteria

* women with medical disorders

Design outcomes

Primary

MeasureTime frameDescription
the number of women who will become pregnant3 monthsnumber of women who will have positive pregnancy test

Countries

Egypt

Contacts

Primary ContactMahmoud Alalfy
mahmoudalalfy@ymail.com01002611058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026